Zoetis to Participate in the 35th Annual J.P. Morgan Healthcare Conference
December 13 2016 - 8:30AM
Business Wire
Zoetis Inc. (NYSE:ZTS) will participate in the 35th Annual J.P.
Morgan Healthcare Conference on Wednesday, Jan. 11, 2017, in San
Francisco, Calif. Juan Ramón Alaix, Chief Executive Officer, will
represent the company and respond to questions from analysts. He is
scheduled to present at 1:00 p.m. EST (10 a.m. PST).
Investors and other interested parties will be able to access a
live audio webcast of the presentation by visiting
http://investor.zoetis.com/events-presentations. A replay of the
presentation will also be available on the Zoetis website at the
conclusion of the event.
About Zoetis
Zoetis is the leading animal health
company, dedicated to supporting its customers and their
businesses. Building on more than 60 years of experience in animal
health, Zoetis discovers, develops, manufactures and markets
veterinary vaccines and medicines, complemented by diagnostic
products and genetic tests and supported by a range of services.
Zoetis serves veterinarians, livestock producers and people who
raise and care for farm and companion animals with sales of its
products in more than 100 countries. In 2015, the company generated
annual revenue of $4.8 billion with approximately 9,000 employees.
For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking
Statements: This press release contains forward-looking
statements, which reflect the current views of Zoetis with respect
to business plans or prospects, future operating or financial
performance, future guidance, future operating models, expectations
regarding products, future use of cash and dividend payments, tax
rate and tax regimes, changes in the tax regimes and
laws in other jurisdictions, and other future events.
These statements are not guarantees of future performance or
actions. Forward-looking statements are subject to risks and
uncertainties. If one or more of these risks or uncertainties
materialize, or if management's underlying assumptions prove to be
incorrect, actual results may differ materially from those
contemplated by a forward-looking statement. Forward-looking
statements speak only as of the date on which they are made. Zoetis
expressly disclaims any obligation to update or revise any
forward-looking statement, whether as a result of new information,
future events or otherwise. A further list and description of
risks, uncertainties and other matters can be found in our Annual
Report on Form 10-K for the fiscal year ended December 31, 2015,
including in the sections thereof captioned “Forward-Looking
Information and Factors That May Affect Future Results” and “Item
1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our
Current Reports on Form 8-K. These filings and subsequent filings
are available online at www.sec.gov, www.zoetis.com, or
on request from Zoetis.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161213005232/en/
Media:ZoetisElinore White,
1-973-443-2835 (o)elinore.y.white@zoetis.comorKristen Seely,
1-973-443-2777 (o)kristen.seely@zoetis.comorInvestors:Steve Frank, 1-973-822-7141
(o)steve.frank@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024